Curiox BioSystems Co

Curiox BioSystems Co Change in Working Capital

The Change in Working Capital of Curiox BioSystems Co (445680.KQ) as of Oct 31, 2026 is 499.84 M KRW. In the previous year, Change in Working Capital was 412.63 M KRW — a change of 21.14% (higher).

Change in Working Capital

499.84 MKRW

YoY

21.14%

Last updated:

Change in Working Capital of Curiox BioSystems Co is 2024 499.84 M KRW. Change in Working Capital of Curiox BioSystems Co was 2023 412.63 M KRW. It decreases by 21.14% higher compared to the previous year.

The Curiox BioSystems Co Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2021
259.60 M KRW
Jan 1, 2022
-670.92 M KRW
Jan 1, 2023
412.63 M KRW
Jan 1, 2024
499.84 M KRW
The Curiox BioSystems Co Change in Working Capital history
YEARChange in Working CapitalYoY
499.84 MKRW+21.14%
412.63 MKRW-161.50%
-670.92 MKRW-358.44%
259.60 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Curiox BioSystems Co Stock analysis

What does Curiox BioSystems Co do? Curiox BioSystems Co Ltd generates revenue through the manufacture and sale of automation equipment and consumables for cell analysis processes. The company offers cell pretreatment automation devices, washing machines, and plates, alongside high-capacity adapters, strip spacers, and buffer exchanger products. These products are sold to customers in the Life Sciences Tools & Services industry, primarily within the Korean market. The firm's focus on automation solutions for cell analysis drives its product portfolio and customer base. The company's product lines include cell pretreatment automation devices, washing machines, plates, high-capacity adapters, strip spacers, and buffer exchanger products. These items are designed for use in cell analysis processes, targeting clients who require efficient and precise laboratory equipment. The sales of these specialized tools form the core of Curiox BioSystems' revenue streams. Curiox BioSystems operates within the Life Sciences Tools & Services industry, focusing on providing automation solutions for cell analysis. Its products are manufactured and sold directly to end-users in the life sciences sector, including research institutions and laboratories. The company's revenue is derived from the direct sale of its equipment and consumables without intermediaries. Curiox BioSystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curiox BioSystems Co stock

Change in Working Capital of Curiox BioSystems Co is 499.84 M KRW in 2024.

Change in Working Capital of Curiox BioSystems Co changed from 412.63 M KRW to 499.84 M KRW, representing a 21.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Curiox BioSystems Co since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Curiox BioSystems Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Curiox BioSystems Co

All Key Metrics — Curiox BioSystems Co